PNC Financial Services Group Inc. Cuts Stake in Roche Holding AG (OTCMKTS:RHHBY)

PNC Financial Services Group Inc. cut its position in shares of Roche Holding AG (OTCMKTS:RHHBY) by 4.5% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 15,911 shares of the company’s stock after selling 751 shares during the period. PNC Financial Services Group Inc.’s holdings in Roche were worth $555,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in RHHBY. Brooklyn Investment Group bought a new stake in shares of Roche in the 3rd quarter valued at approximately $40,000. IHT Wealth Management LLC bought a new stake in shares of Roche in the 3rd quarter valued at approximately $236,000. Canopy Partners LLC lifted its stake in shares of Roche by 4.6% in the 3rd quarter. Canopy Partners LLC now owns 7,772 shares of the company’s stock valued at $310,000 after purchasing an additional 344 shares during the last quarter. Verity Asset Management Inc. lifted its stake in shares of Roche by 26.8% in the 4th quarter. Verity Asset Management Inc. now owns 8,036 shares of the company’s stock valued at $280,000 after purchasing an additional 1,697 shares during the last quarter. Finally, Confluence Investment Management LLC lifted its stake in shares of Roche by 26.3% in the 4th quarter. Confluence Investment Management LLC now owns 13,981 shares of the company’s stock valued at $488,000 after purchasing an additional 2,910 shares during the last quarter.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on RHHBY shares. Sanford C. Bernstein raised Roche to a “strong-buy” rating in a research note on Thursday, January 30th. UBS Group raised Roche from a “hold” rating to a “strong-buy” rating in a research note on Thursday, February 13th. Finally, Morgan Stanley began coverage on Roche in a research note on Wednesday, February 12th. They set an “equal weight” rating for the company. Two analysts have rated the stock with a sell rating, one has issued a hold rating, one has given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, Roche presently has a consensus rating of “Moderate Buy”.

Roche Price Performance

Shares of RHHBY stock opened at $43.36 on Thursday. Roche Holding AG has a 52-week low of $29.20 and a 52-week high of $44.31. The company has a debt-to-equity ratio of 0.86, a current ratio of 1.26 and a quick ratio of 0.97. The stock has a 50 day moving average price of $40.27 and a 200 day moving average price of $38.57.

Roche Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.